StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.42+0.20 (+6.21%)

Close on Nov 18, 2026Market cap $43.94MP/E –Yield –

Clene net income

Net income is the profit left for shareholders after every expense, interest and tax.

Clene's net income for the twelve months ending Jun 30, 2026 was -$39.52M. For fiscal 2025 it was -$26.17M. The highest annual figure on record is -$9.74M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$26.17M–
FY2024Dec 31, 2024-$39.40M–
FY2023Dec 31, 2023-$49.50M–
FY2022Dec 31, 2022-$29.92M–
FY2021Dec 31, 2021-$9.74M–
FY2020Dec 31, 2020-$19.28M–
FY2019Dec 31, 2019-$16.16M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$13.42M–
Q1 FY2026Mar 31, 2026-$8.09M–
Q4 FY2025Dec 31, 2025-$9.23M–
Q3 FY2025Sep 30, 2025-$8.78M–
Q2 FY2025Jun 30, 2025-$7.42M–
Q1 FY2025Mar 31, 2025-$751.00K–
Q4 FY2024Dec 31, 2024-$13.55M–
Q3 FY2024Sep 30, 2024-$7.99M–
Q2 FY2024Jun 30, 2024-$6.79M–
Q1 FY2024Mar 31, 2024-$11.08M–
Q4 FY2023Dec 31, 2023-$10.17M–
Q3 FY2023Sep 30, 2023-$2.42M–
Q2 FY2023Jun 30, 2023-$25.14M-668.5%
Q1 FY2023Mar 31, 2023-$11.77M-140.7%
Q2 FY2022Jun 30, 2022-$4.53M–
Q1 FY2022Mar 31, 2022-$13.35M–
Q4 FY2021Dec 31, 2021$4.42M+468.5%
Q3 FY2021Sep 30, 2021$28.94M–
Q2 FY2021Jun 30, 2021-$3.35M–
Q1 FY2021Mar 31, 2021-$39.76M–
Q4 FY2020Dec 31, 2020$778.00K–
Q3 FY2020Sep 30, 2020-$10.30M–
Q2 FY2020Jun 30, 2020-$5.82M–
Q1 FY2020Mar 31, 2020-$3.94M–

More Clene figures

See a number that looks wrong?